Table 2. Summary of impacts of compounds on healthy volunteer and keloid fibroblasts.
Summary of impacts of the glycolysis inhibitor (2DG), the mitochondrial ATP inhibitor (rotenone), caffeine, allicin, and shikonin on scratch assay healing time, extracellular acidification rate (ECAR), mitochondrial ATP production (Mito-ATP), non-Mito-ATP, the proinflammatory interleukin (IL-)6, and the neutrophil chemokine CXCL1.
| Stimulant | EMT | ECAR | Mito-ATP | Non-Mito-ATP | IL-6 | CXCL1 |
|---|---|---|---|---|---|---|
| Healthy volunteer fibroblast cell line | ||||||
| 2DG | ___ | ↓ | ___ | ↓ | ↓ | ↓ |
| Rotenone | ___ | ___ | ↓ | ___ | ↓ | ___ |
| Caffeine | ↓ | ___ | ↓ | ↓ | ___ | ___ |
| Allicin | ↓ | ___ | ↓ | ↓ | ↓ | ↓ |
| Shikonin | ↓ | ___ | ___ | ___ | ___ | ↓ |
| Keloid fibroblast cell line | ||||||
| Keloid derived (vs HV-FB) | ↑ | ↑ | ↓ | ___ | ↑ | ↓ |
| 2DG | ↓ | ↓ | ___ | ↓ | ↓ | ↓ |
| Rotenone | ___ | ___ | ↓ | ___ | ↓ | ___ |
| Caffeine | ↓ | ___ | ↓ | ↓ | ___ | ___ |
| Allicin | ↓ | ___ | ↓ | ↓ | ↓ | ↓ |
| Shikonin | ↓ | ___ | ↓ | ___ | ↓ | ↓ |